| 1 | added value through supply | | | | | | | 7 | 3.04% |
| 2 | through supply service and | | | | | | | 6 | 2.61% |
| 3 | supply service and price | | | | | | | 5 | 2.17% |
| 4 | value through supply service | | | | | | | 5 | 2.17% |
| 5 | delivering added value through | | | | | | | 5 | 2.17% |
| 6 | supply service and pricedelivering | | | | | | | 3 | 1.30% |
| 7 | us delivering added value | | | | | | | 2 | 0.87% |
| 8 | a consistent supply of | | | | | | | 2 | 0.87% |
| 9 | service and price pigenericotcemp | | | | | | | 2 | 0.87% |
| 10 | pricedelivering added value through | | | | | | | 2 | 0.87% |
| 11 | and pricedelivering added value | | | | | | | 2 | 0.87% |
| 12 | service and pricedelivering added | | | | | | | 2 | 0.87% |
| 13 | service and price delivering | | | | | | | 2 | 0.87% |
| 14 | and price pigenericotcemp contact | | | | | | | 2 | 0.87% |
| 15 | pharmaceuticals home contact us | | | | | | | 2 | 0.87% |
| 16 | pharmaceuticals merit pharmaceuticalsmerit pharmaceuticalsmerit | | | | | | | 2 | 0.87% |
| 17 | lead intermittently to restrictions | | | | | | | 1 | 0.43% |
| 18 | we understand that the | | | | | | | 1 | 0.43% |
| 19 | understand that the nature | | | | | | | 1 | 0.43% |
| 20 | that the nature of | | | | | | | 1 | 0.43% |
| 21 | will relive your concerns | | | | | | | 1 | 0.43% |
| 22 | the nature of the | | | | | | | 1 | 0.43% |
| 23 | pharmaceuticals will relive your | | | | | | | 1 | 0.43% |
| 24 | the retail pharmacist merit | | | | | | | 1 | 0.43% |
| 25 | problems for the retail | | | | | | | 1 | 0.43% |
| 26 | for the retail pharmacist | | | | | | | 1 | 0.43% |
| 27 | intermittently to restrictions on | | | | | | | 1 | 0.43% |
| 28 | industry can lead intermittently | | | | | | | 1 | 0.43% |
| 29 | can lead intermittently to | | | | | | | 1 | 0.43% |
| 30 | management problems for the | | | | | | | 1 | 0.43% |
| 31 | inventory management problems for | | | | | | | 1 | 0.43% |
| 32 | restrictions on stock causing | | | | | | | 1 | 0.43% |
| 33 | pharmaceutical supply we understand | | | | | | | 1 | 0.43% |
| 34 | to restrictions on stock | | | | | | | 1 | 0.43% |
| 35 | supply we understand that | | | | | | | 1 | 0.43% |
| 36 | merit pharmaceuticals merit pharmaceuticalsmerit | | | | | | | 1 | 0.43% |
| 37 | merit pharmaceutical supply we | | | | | | | 1 | 0.43% |
| 38 | supply of the most | | | | | | | 1 | 0.43% |
| 39 | medicines ensures that each | | | | | | | 1 | 0.43% |
| 40 | ensures that each month | | | | | | | 1 | 0.43% |